핵의학

본문글자크기
  • [Behav Brain Res.] Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging.

    천안보건소, KAIST / 최홍윤*, 진경환*

  • 출처
    Behav Brain Res.
  • 등재일
    2018 May 15
  • 저널이슈번호
    344:103-109. doi: 10.1016/j.bbr.2018.02.017. Epub 2018 Feb 14.
  • 내용

    바로가기  >

    Abstract
    For effective treatment of Alzheimer's disease (AD), it is important to identify subjects who are most likely to exhibit rapid cognitive decline. We aimed to develop an automatic image interpretation system based on a deep convolutional neural network (CNN) which can accurately predict future cognitive decline in mild cognitive impairment (MCI) patients using flurodeoxyglucose and florbetapir positron emission tomography (PET). PET images of 139 patients with AD, 171 patients with MCI and 182 normal subjects obtained from Alzheimer's Disease Neuroimaging Initiative database were used. Deep CNN was trained using 3-dimensional PET volumes of AD and normal controls as inputs. Manually defined image feature extraction such as quantification using predefined region-of-interests was unnecessary for our approach. Furthermore, it used minimally processed images without spatial normalization which has been commonly used in conventional quantitative analyses. Cognitive outcome of MCI subjects was predicted using this network. The prediction accuracy of the conversion of mild cognitive impairment to AD was compared with the conventional feature-based quantification approach. Accuracy of prediction (84.2%) for conversion to AD in MCI patients outperformed conventional feature-based quantification approaches. ROC analyses revealed that performance of CNN-based approach was significantly higher than that of the conventional quantification methods (p < 0.05). Output scores of the network were strongly correlated with the longitudinal change in cognitive measurements (p < 0.05). These results show the feasibility of deep learning as a practical tool for developing predictive neuroimaging biomarker.

     


    Author information

    Choi H1, Jin KH2; Alzheimer’s Disease Neuroimaging Initiative.
    1
    Cheonan Public Health Center, Chungnam, Republic of Korea. Electronic address: chy1000@snu.ac.kr.
    2
    Biomedical Imaging Group, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea. Electronic address: kyong.jin@epfl.ch.

  • 키워드
    Alzheimer’s disease; Amyloid; Brain PET; Convolutional neural network; Deep learning
  • 덧글달기
    덧글달기
       IP : 18.226.222.12

    등록